Palmitoylation of the V2 vasopressin receptor.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Molecular Pharmacology

• Publication date

  1997-07-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1124/MOL.52.1.21PMID 9224808
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Palmitoylation in G-protein signaling pathways The reversible palmitoylation of G proteins and their receptors is involved both in receptor desensitization and in association and disassociation

  2004cited by this paper
• Modification of proteins with covalent lipids

  2003cited by this paper
• Phosphorylation of the V2 Vasopressin Receptor*

  1997cited by this paper
• An X-linked NDI mutation reveals a requirement for cell surface V2R expression.

  1997cited by this paper
• Maturation of receptor proteins in eukaryotic expression systems.

  1997cited by this paper
• Agonist stimulation increases the turnover rate of beta 2AR-bound palmitate and promotes receptor depalmitoylation.

  1996cited by this paper
• A fully active nonglycosylated V2 vasopressin receptor.

  1996cited by this paper
• Properties of the human arginine vasopressin V2 receptor after site-directed mutagenesis of its putative palmitoylation site.

  1996cited by this paper
• Palmitoylated Cysteine 341 Modulates Phosphorylation of the β2-Adrenergic Receptor by the cAMP-dependent Protein Kinase*

  1996cited by this paper
• Palmitoylation of G-protein alpha subunits.

  1995cited by this paper
• Palmitoylation of G-protein alpha subunits.

  1995cited by this paper
• Dynamic regulation of G-protein coupled receptor palmitoylation: potential role in receptor function.

  1995cited by this paper
• Detecting radiolabeled lipid-modified proteins in polyacrylamide gels.

  1995cited by this paper
• Palmitoylation of luteinizing hormone/human choriogonadotropin receptors in transfected cells. Abolition of palmitoylation by mutation of Cys-621 and Cys-622 residues in the cytoplasmic tail increases ligand-induced internalization of the receptor.

  1994cited by this paper
• An extracellular congenital nephrogenic diabetes insipidus mutation of the vasopressin receptor reduces cell surface expression, affinity for ligand, and coupling to the Gs/adenylyl cyclase system.

  1994cited by this paper
• Mutations of the alpha 2A-adrenergic receptor that eliminate detectable palmitoylation do not perturb receptor-G-protein coupling.

  1993cited by this paper
• Palmitoylation of bovine opsin and its cysteine mutants in COS cells.

  1993cited by this paper
• The alpha 2A-adrenergic receptor is targeted directly to the basolateral membrane domain of Madin-Darby canine kidney cells independent of coupling to pertussis toxin-sensitive GTP-binding proteins.

  1993cited by this paper
• Agonist-modulated palmitoylation of beta 2-adrenergic receptor in Sf9 cells.

  1992cited by this paper
• Palmitoylation of the human beta 2-adrenergic receptor. Mutation of Cys341 in the carboxyl tail leads to an uncoupled nonpalmitoylated form of the receptor.

  1989cited by this paper
• Palmitylation of viral membrane glycoproteins takes place after exit from the endoplasmic reticulum.

  1989cited by this paper
• Two adjacent cysteine residues in the C‐terminal cytoplasmic fragment of bovine rhodopsin are palmitylated

  1988cited by this paper
• High efficiency polyoma DNA transfection of chloroquine treated cells.

  1983cited by this paper
• DNA sequencing with chain-terminating inhibitors.

  1977cited by this paper
• Hormone-stimulated desensitization of hormone-dependent adenylyl cyclase. Dual action of luteninizing hormone on pig graafian follicle membranes.

  1976cited by this paper
• A highly sensitive adenylate cyclase assay.

  1974cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• A small molecule stabilizer rescues the surface expression of nearly all missense variants in a GPCR

  2025cites this paper
• Post-Translational Modifications of G Protein–Coupled Receptors Control Cellular Signaling Dynamics in Space and Time

  2020cites this paper
• Vasopressin actions in the kidney renin angiotensin system and its role in hypertension and renal disease.

  2020cites this paper
• Artificial signaling in mammalian cells enabled by prokaryotic two-component system

  2019cites this paper
• Intrinsically Disordered Proteins Link Alternative Splicing and Post-translational Modifications to Complex Cell Signaling and Regulation.

  2018cites this paper
• Palmitoylation as a Functional Regulator of Neurotransmitter Receptors

  2018cites this paper
• Novel de novo AVPR 2 Variant in a Patient with Congenital Nephrogenic Diabetes Insipidus

  2017cites this paper
• Novel de novo AVPR2 Variant in a Patient with Congenital Nephrogenic Diabetes Insipidus

  2017cites this paper
• Characterization of vasopressin V 2 receptor mutants in nephrogenic diabetes insipidus in a polarized cell model

  2017cites this paper
• Human adenosine A2A receptor binds calmodulin with high affinity in a calcium-dependent manner.

  2015cites this paper
• The physiological and pathophysiological functions of renal and extrarenal vasopressin V2 receptors.

  2014cites this paper
• Receptors for Neuronal or Endocrine Signalling Molecules as Potential Targets for the Control of Insect Pests

  2014cites this paper
• Rôle de la vasopressine dans les troubles du métabolisme glucidique : possible impact dans le développement du diabète

  2014cites this paper
• Clathrin-mediated endocytosis in the mechanism of antidiuretic action of vasopressin

  2013cites this paper
• The Cell Biology of Vasopressin Action

  2012cites this paper
• Conséquences fonctionnelles de mutations affectant le récepteur de la vasopressine de type 2 et implications thérapeutiques

  2012cites this paper
• Palmitoylation of human proteinase-activated receptor-2 differentially regulates receptor-triggered ERK1/2 activation, calcium signalling and endocytosis.

  2011cites this paper
• The Role of Palmitoylation in Signalling, Cellular Trafficking and Plasma Membrane Localization of Protease-Activated Receptor-2

  2011influential citation
• Human δ opioid receptor Phe27 and Cys27 variants : the role of heteromerization and pharmacological chaperones in receptor processing and trafficking

  2011cites this paper
• Oxytocin increases glucose uptake in neonatal rat cardiomyocytes.

  2010cites this paper
• G-protein-coupled receptors, cholesterol and palmitoylation: facts about fats.

  2009cites this paper
• Palmitoylation of the P2X7 receptor, an ATP‐gated channel, controls its expression and association with lipid rafts

  2009cites this paper
• Molecular Biology and Gene Regulation of Vasopressin

  2009cites this paper
• Oligomerization of the heptahelical G protein coupling receptors: a case for association using transmembrane helices.

  2009cites this paper
• The role of palmitoylation in endoplasmic reticulum transport and quality control of the yeast polytopic protein Chs3

  2009cites this paper
• Functional Analysis of Yeast Pheromone Receptors in ER Exit, Ligand-Induced Endocytosis and Oligomerization: A Dissertation

  2009cites this paper
• Constitutive Gs-mediated, but not G12-mediated, activity of the 5-hydroxytryptamine 5-HT7(a) receptor is modulated by the palmitoylation of its C-terminal domain.

  2009cites this paper
• Novel regulatory mechanisms of D1 dopamine receptor maturation and internalization.

  2008cites this paper
• Protein-protein interactions in GCR1 signalling in Arabidopsis thaliana

  2008cites this paper
• Cysteine Pairs in the Third Intracellular Loop of the Muscarinic M1 Acetylcholine Receptor Play a Role in Agonist-Induced Internalization

  2008cites this paper
• Small-Molecule Vasopressin-2 Receptor Antagonist Identified by a G-Protein Coupled Receptor “Pathway” Screen

  2007cites this paper
• Role of palmitoylation in the serotonin receptor functioning

  2007cites this paper
• Co-ordinated covalent modification of G-protein coupled receptors.

  2006cites this paper
• A Role for ADP-ribosylation Factor 6 in the Processing of G-protein-coupled Receptors*

  2006cites this paper
• Molecular basis and clinical features of nephrogenic diabetes insipidus

  2006cites this paper
• A Novel C-terminal Motif Is Necessary for the Export of the Vasopressin V1b/V3 Receptor to the Plasma Membrane*

  2005cites this paper
• Characterization of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus in a polarized cell model.

  2005cites this paper
• Palmitoylation of claudins is required for efficient tight-junction localization

  2005cites this paper
• Monitoring agonist‐promoted conformational changes of β‐arrestin in living cells by intramolecular BRET

  2005influential citation
• Palmitoylation of the 5-Hydroxytryptamine4a Receptor Regulates Receptor Phosphorylation, Desensitization, and β-Arrestin-Mediated Endocytosis

  2005cites this paper
• G-protein-coupled receptor phosphorylation and palmitoylation.

  2004cites this paper
• The Palmitoylation of Metastasis Suppressor KAI1/CD82 Is Important for Its Motility- and Invasiveness-Inhibitory Activity

  2004cites this paper
• Functional rescue of the constitutively internalized V2 vasopressin receptor mutant R137H by the pharmacological chaperone action of SR49059.

  2004cites this paper
• Cloning of Octopus cephalotocin receptor, a member of the oxytocin/vasopressin superfamily.

  2003cites this paper
• Palmitoylation of the V2 Vasopressin Receptor Carboxyl Tail Enhances β-Arrestin Recruitment Leading to Efficient Receptor Endocytosis and ERK1/2 Activation*

  2003cites this paper
• Role of palmitoylation/depalmitoylation reactions in G-protein-coupled receptor function.

  2003cites this paper
• Control of signalling efficacy by palmitoylation of the rat Y1 receptor

  2003influential citation
• The 5-Hydroxytryptamine(4a) Receptor Is Palmitoylated at Two Different Sites, and Acylation Is Critically Involved in Regulation of Receptor Constitutive Activity*

  2002cites this paper
• Palmitoylation of CCR5 Is Critical for Receptor Trafficking and Efficient Activation of Intracellular Signaling Pathways*

  2001cites this paper
• Molekulare Grundlagen des Diabetes insipidus centralis und renalis

  2001influential citation
• The oxytocin receptor system: structure, function, and regulation.

  2001cites this paper
• Coupling of endothelin receptors to the ERK/MAP kinase pathway. Roles of palmitoylation and G(alpha)q.

  2001cites this paper
• Palmitoylation-dependent Control of Degradation, Life Span, and Membrane Expression of the CCR5 Receptor*

  2001cites this paper
• Role of the human V1 vasopressin receptor COOH terminus in internalization and mitogenic signal transduction.

  2001cites this paper
• Palmitoylation of the vasopressin V1a receptor reveals different conformational requirements for signaling, agonist-induced receptor phosphorylation, and sequestration.

  2001cites this paper
• The basic and clinical pharmacology of nonpeptide vasopressin receptor antagonists.

  2001cites this paper
• Thioacylation is required for targeting G-protein subunit G(o1alpha) to detergent-insoluble caveolin-containing membrane domains.

  2001cites this paper
• Coordinated agonist regulation of receptor and G protein palmitoylation and functional rescue of palmitoylation-deficient mutants of the G protein G11alpha following fusion to the alpha1b-adrenoreceptor: palmitoylation of G11alpha is not required for interaction with beta*gamma complex.

  2001cites this paper
• Analysis of the C-terminal tail of the rat thyrotropin-releasing hormone receptor-1 in interactions and cointernalization with beta-arrestin 1-green fluorescent protein.

  2001cites this paper
• Vasopressin receptors.

  2000cites this paper
• Characterization of a novel porcine endothelin(B) receptor splice variant.

  2000cites this paper
• Immunologic differentiation of two high‐affinity neurotensin receptor isoforms in the developing rat brain

  2000cites this paper
• Pivotal role for the cytoplasmic carboxyl-terminal tail of a nonmammalian gonadotropin-releasing hormone receptor in cell surface expression, ligand binding, and receptor phosphorylation and internalization.

  1999cites this paper
• Vasopressin receptors: structural functional relationships and role in neural and endocrine regulation.

  1999cites this paper
• Vasopressin receptor mutations and nephrogenic diabetes insipidus.

  1999cites this paper
• The oxytocin receptor.

  1999cites this paper
• Palmitoylation of the three isoforms of human endothelin-converting enzyme-1.

  1999cites this paper
• Molecular dynamics of a vasopressin V2 receptor in a phospholipid bilayer membrane.

  1999cites this paper
• Role of the carboxyl‐terminal region, di‐leucine motif and cysteine residues in signalling and internalization of vasopressin V1a receptor

  1999cites this paper
• Palmitoylation occurs at cysteine 347 and cysteine 351 of the dopamine D(1) receptor.

  1999cites this paper
• Palmitoylation of the recombinant human A1 adenosine receptor: enhanced proteolysis of palmitoylation-deficient mutant receptors.

  1999cites this paper
• Gene and cDNA cloning and characterization of the mouse V3/V1b pituitary vasopressin receptor.

  1999cites this paper
• G Protein-coupled receptor–bioligand interactions modeled in a phospholipid bilayer

  1999cites this paper
• Regional time-dependent changes in vasopressin V2 receptor expression in the rat kidney during water restriction.

  1998cites this paper
• Palmitoylation of human thyrotropin receptor: slower intracellular trafficking of the palmitoylation-defective mutant.

  1998cites this paper
• Posttranslational modifications of endothelin receptor type B.

  1998cites this paper
• Palmitoylation of the cytoplasmic domain of the neural cell adhesion molecule N-CAM serves as an anchor to cellular membranes.

  1998cites this paper
• Folding and cell surface expression of the vasopressin V2 receptor: requirement of the intracellular C‐terminus

  1998cites this paper
• A serine cluster prevents recycling of the V2 vasopressin receptor.

  1998cites this paper
• Molecular Basis of V2 Vasopressin Receptor/GsCoupling Selectivity*

  1998cites this paper
• Regional time-dependent changes in vasopressin V2 receptor expression in the rat kidney during water restriction.

  1998cites this paper
• Structural bases of vasopressin/oxytocin receptor function.

  1998cites this paper
• Vasopressin V1a and V2 receptor mRNA in deoxycorticosterone acetate-salt hypertension in the rat.

  1998cites this paper
• Processing and ligand-induced modifications of the V2 vasopressin receptor.

  1998cites this paper